stockrowStevanato Group S.p.A.
STVN Healthcare Medical Instruments & Supplies
Stevanato Group S.p.A.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 12.3% from fiscal 2024.
- Revenue
- +5.91%
- EPS
- +17.5%
- Free cash flow
- +4,089.9%
- Total debt
- +2.85%
Quarter to September 2026, against a year earlier
Follow STVN
Alert me
Stevanato Group S.p.A. (STVN) Operating cash flow
Stevanato Group S.p.A.'s operating cash flow for fiscal 2025 was $323.7M, up 92.0% from $168.6M in fiscal 2024. Over the twelve months to 30 September 2026 it was $289.2M. Over the past ten years it has ranged from $47.6M (fiscal 2019) to $323.7M (fiscal 2025) — the current reading is the highest in ten years. Operating cash flow has risen for 3 consecutive fiscal years. Stevanato Group S.p.A. ranks 15th of 51 Medical Instruments & Supplies companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $323.7M | 92.01% |
| FY2024 | $168.6M | 48.03% |
| FY2023 | $113.9M | 4.61% |
| FY2022 | $108.8M | (31.00%) |
| FY2021 | $157.7M | (11.28%) |
| FY2020 | $177.8M | 273.16% |
| FY2019 | $47.6M | — |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $65.1M | 78.49% |
| Jun 2026 | $36.5M | (58.73%) |
| Mar 2026 | $88.4M | (11.00%) |
| Dec 2025 | $99.3M | 65.24% |
| 23 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| NVST Envista Holdings Corporation compare | $301.8M |
| STVN Stevanato Group S.p.A. | $289.2M |
| ICUI ICU Medical, Inc. compare | $279.2M |
| MMSI Merit Medical Systems, Inc. compare | $273.7M |
| TFX Teleflex Incorporated compare | $129.3M |
| WRBY Warby Parker Inc. compare | $102.1M |
| ATRC AtriCure, Inc. compare | $68.5M |
| PLSE Pulse Biosciences, Inc compare | −$63.3M |
| MMED MiniMed Group, Inc. compare | −$134.0M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on STVN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement